BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 23812602)

  • 1. Starting and stopping SUMOylation. What regulates the regulator?
    Watts FZ
    Chromosoma; 2013 Dec; 122(6):451-63. PubMed ID: 23812602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of biochemically distinct properties of the small ubiquitin-related modifier (SUMO) conjugation pathway in Plasmodium falciparum.
    Reiter K; Mukhopadhyay D; Zhang H; Boucher LE; Kumar N; Bosch J; Matunis MJ
    J Biol Chem; 2013 Sep; 288(39):27724-36. PubMed ID: 23943616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.
    Coey CT; Fitzgerald ME; Maiti A; Reiter KH; Guzzo CM; Matunis MJ; Drohat AC
    J Biol Chem; 2014 May; 289(22):15810-9. PubMed ID: 24753249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMO pathway components as possible cancer biomarkers.
    Mattoscio D; Chiocca S
    Future Oncol; 2015; 11(11):1599-610. PubMed ID: 26043214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation.
    Licciardello MP; Müllner MK; Dürnberger G; Kerzendorfer C; Boidol B; Trefzer C; Sdelci S; Berg T; Penz T; Schuster M; Bock C; Kralovics R; Superti-Furga G; Colinge J; Nijman SM; Kubicek S
    Oncogene; 2015 Jul; 34(29):3780-90. PubMed ID: 25263445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insights into functional modes of proteins involved in ubiquitin family pathways.
    Hänzelmann P; Schäfer A; Völler D; Schindelin H
    Methods Mol Biol; 2012; 832():547-76. PubMed ID: 22350912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sumoylation of human argonaute 2 at lysine-402 regulates its stability.
    Sahin U; Lapaquette P; Andrieux A; Faure G; Dejean A
    PLoS One; 2014; 9(7):e102957. PubMed ID: 25036361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells.
    Huang CH; Yang TT; Lin KI
    J Biomed Sci; 2024 Jan; 31(1):16. PubMed ID: 38280996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical characterization of SUMO-conjugating enzymes by in vitro sumoylation assays.
    Eisenhardt N; Ilic D; Nagamalleswari E; Pichler A
    Methods Enzymol; 2019; 618():167-185. PubMed ID: 30850051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the sumoylation system in gene expression.
    Liu B; Shuai K
    Curr Opin Cell Biol; 2008 Jun; 20(3):288-93. PubMed ID: 18468876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMO: getting it on.
    Anckar J; Sistonen L
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1409-13. PubMed ID: 18031233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SUMO components in rheumatoid arthritis.
    Wu Q; Jiang Y; You C
    Rheumatology (Oxford); 2022 Nov; 61(12):4619-4630. PubMed ID: 35595244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
    Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
    J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tools to Study SUMO Conjugation in Caenorhabditis elegans.
    Pelisch F; Hay RT
    Methods Mol Biol; 2016; 1475():233-56. PubMed ID: 27631810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes.
    Bossis G; Melchior F
    Mol Cell; 2006 Feb; 21(3):349-57. PubMed ID: 16455490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SUMO, Ubiquitin, UBL Proteins: Implications For Human Diseases - Fifth International Conference.
    Skaug B; Chen ZJ
    IDrugs; 2010 Apr; 13(4):224-7. PubMed ID: 20373248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamin interacts with members of the sumoylation machinery.
    Mishra RK; Jatiani SS; Kumar A; Simhadri VR; Hosur RV; Mittal R
    J Biol Chem; 2004 Jul; 279(30):31445-54. PubMed ID: 15123615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small ubiquitin-like modifier (SUMO) modification of E1 Cys domain inhibits E1 Cys domain enzymatic activity.
    Truong K; Lee TD; Chen Y
    J Biol Chem; 2012 May; 287(19):15154-63. PubMed ID: 22403398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced detection of in vivo SUMO conjugation by Ubc9 fusion-dependent sumoylation (UFDS).
    Niedenthal R
    Methods Mol Biol; 2009; 497():63-79. PubMed ID: 19107411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMO regulates the activity of Smoothened and Costal-2 in Drosophila Hedgehog signaling.
    Zhang J; Liu Y; Jiang K; Jia J
    Sci Rep; 2017 Feb; 7():42749. PubMed ID: 28195188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.